PT1673370E
(pt)
|
2003-10-16 |
2009-11-05 |
Symed Labs Ltd |
Forma cristalina de linezolida
|
ES2294494T3
(es)
*
|
2004-04-19 |
2008-04-01 |
Symed Labs Limited |
Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados.
|
CN102442970A
(zh)
|
2006-05-31 |
2012-05-09 |
雅培制药有限公司 |
用作大麻素受体配位体的噻唑化合物及其用途
|
CA2647598A1
(en)
|
2006-05-31 |
2007-12-06 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands and uses thereof
|
US8841334B2
(en)
|
2006-05-31 |
2014-09-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
US7875640B2
(en)
|
2007-03-28 |
2011-01-25 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US7872033B2
(en)
|
2007-04-17 |
2011-01-18 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8501794B2
(en)
|
2007-04-17 |
2013-08-06 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
WO2008144360A1
(en)
|
2007-05-18 |
2008-11-27 |
Abbott Laboratories |
Novel compounds as cannabinoid receptor ligands
|
US9193713B2
(en)
|
2007-10-12 |
2015-11-24 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
MX2010010023A
(es)
|
2008-03-11 |
2010-11-30 |
Abbott Lab |
Compuestos novedosos como ligandos receptores de canabinoides.
|
MX2010010773A
(es)
|
2008-04-01 |
2011-04-11 |
Abbott Gmbh & Co Kg |
Tetrahidroisoquinolinas, composiciones farmaceuticas que las contienen y su uso en terapia.
|
CA2731102A1
(en)
|
2008-08-15 |
2010-02-18 |
Abbott Laboratories |
Imine derivatives as cannabinoid receptor ligands
|
US8846730B2
(en)
|
2008-09-08 |
2014-09-30 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
KR20110061619A
(ko)
|
2008-09-16 |
2011-06-09 |
아보트 러보러터리즈 |
칸나비노이드 수용체 리간드로서의 치환된 벤즈아미드
|
MX2011004090A
(es)
|
2008-10-17 |
2011-05-31 |
Abbott Lab |
Antagonistas trpv1.
|
US8604053B2
(en)
|
2008-10-17 |
2013-12-10 |
Abbvie Inc. |
TRPV1 antagonists
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8557983B2
(en)
|
2008-12-04 |
2013-10-15 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
UA108193C2
(uk)
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
JP5684720B2
(ja)
|
2008-12-05 |
2015-03-18 |
アッヴィ・インコーポレイテッド |
癌および免疫疾患の治療のためのbcl−2−選択的アポトーシス誘発剤としてのスルホンアミド誘導体
|
US8586754B2
(en)
|
2008-12-05 |
2013-11-19 |
Abbvie Inc. |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
US8563735B2
(en)
|
2008-12-05 |
2013-10-22 |
Abbvie Inc. |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
PA8854001A1
(es)
|
2008-12-16 |
2010-07-27 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de canabinoides
|
CN101774978B
(zh)
|
2009-01-13 |
2011-09-21 |
联化科技股份有限公司 |
一种利奈唑胺的制备方法及其中间体
|
KR20110116161A
(ko)
|
2009-01-19 |
2011-10-25 |
아보트 러보러터리즈 |
암, 면역 질환 및 자가면역 질환의 치료를 위한 아폽토시스-유도제
|
DK2511264T3
(da)
|
2009-01-19 |
2015-06-22 |
Abbvie Inc |
Apoptose-inducerende midler til behandling af cancer og immunsygdomme og autoimmune sygdomme
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
|
US8288428B2
(en)
|
2009-03-27 |
2012-10-16 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2010111574A1
(en)
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8492371B2
(en)
|
2009-03-27 |
2013-07-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US8507493B2
(en)
|
2009-04-20 |
2013-08-13 |
Abbvie Inc. |
Amide and amidine derivatives and uses thereof
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
RU2535347C3
(ru)
|
2009-05-26 |
2019-05-14 |
ЭббВи Айэленд Анлимитед Компани |
Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунных и аутоиммунных заболеваний
|
US9034875B2
(en)
|
2009-05-26 |
2015-05-19 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US20220315555A1
(en)
|
2009-05-26 |
2022-10-06 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8962639B2
(en)
|
2009-05-29 |
2015-02-24 |
Abbvie Inc. |
Potassium channel modulators
|
WO2011053740A1
(en)
|
2009-10-28 |
2011-05-05 |
Belkin International, Inc. |
Portable multi-media communication device protective carrier and method of manufacture therefor
|
JP2013512241A
(ja)
|
2009-11-25 |
2013-04-11 |
アボット・ラボラトリーズ |
カリウムチャネルモジュレーター
|
TW201130855A
(en)
|
2009-12-16 |
2011-09-16 |
Abbott Lab |
Prodrug compounds useful as cannabinoid ligands
|
EP2516408A1
(de)
|
2009-12-26 |
2012-10-31 |
Alembic Pharmaceuticals Limited |
Verfahren zur herstellung von linezolid
|
CN102947283B
(zh)
|
2010-03-25 |
2015-10-07 |
Abbvie公司 |
用于治疗癌症和免疫以及自身免疫性疾病的细胞凋亡诱导剂
|
KR20130108975A
(ko)
|
2010-04-30 |
2013-10-07 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코포레이션 |
리네졸리드의 제조 방법
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
US8586596B2
(en)
|
2010-06-15 |
2013-11-19 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
CN102311400A
(zh)
*
|
2010-06-29 |
2012-01-11 |
翔真生物科技股份有限公司 |
制备5-左旋-氨甲基-3-芳基-2-恶唑烷酮类的方法
|
CN103140476A
(zh)
|
2010-08-10 |
2013-06-05 |
Abbvie公司 |
新颖的trpv3调节剂
|
EP2603505A1
(de)
|
2010-08-11 |
2013-06-19 |
Synthon BV |
Verfahren zur herstellung von linezolid
|
EP2690100A1
(de)
|
2010-08-11 |
2014-01-29 |
Synhton B.V. |
Verfahren zur Linezpolid Herstellung
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
AU2011300365A1
(en)
|
2010-09-07 |
2013-05-02 |
Symed Labs Limited |
Processes for the preparation of 4-{4-[5(S)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl} morpholin-3-one
|
CN103119035B
(zh)
|
2010-09-27 |
2015-09-30 |
雅培股份有限两合公司 |
杂环化合物和它们作为糖原合成酶激酶-3抑制剂的用途
|
SG189471A1
(en)
|
2010-10-29 |
2013-05-31 |
Abbvie Inc |
Solid dispersions containing an apoptosis-inducing agent
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
WO2012067963A1
(en)
|
2010-11-15 |
2012-05-24 |
Abbott Laboratories |
Nampt inhibitors
|
MX2013005454A
(es)
|
2010-11-15 |
2013-06-24 |
Abbvie Inc |
Inhibidores de nampt y rock.
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
WO2012067824A1
(en)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Potassium channel modulators
|
DK2642999T3
(en)
|
2010-11-23 |
2017-01-09 |
Abbvie Ireland Unlimited Co |
METHODS OF TREATMENT FOR USING selectivity-VE BCL-2 INHIBITORS
|
RU2628560C2
(ru)
|
2010-11-23 |
2017-08-18 |
Эббви Инк. |
Соли и кристаллические формы индуцирующего апоптоз агента
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
CN103391927A
(zh)
|
2011-02-24 |
2013-11-13 |
李药业有限公司 |
利奈唑胺及其新中间体的新制备方法
|
US8802693B1
(en)
|
2011-03-09 |
2014-08-12 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
WO2012129491A1
(en)
|
2011-03-24 |
2012-09-27 |
Abbott Laboratories |
Trpv3 modulators
|
CA2831146C
(en)
|
2011-03-25 |
2019-06-04 |
Abbvie Inc. |
Trpv1 antagonists
|
WO2012140061A1
(en)
*
|
2011-04-11 |
2012-10-18 |
Sandoz Ag |
Method for the preparation of substituted oxazolidinones
|
CN102229577A
(zh)
*
|
2011-05-11 |
2011-11-02 |
石药集团中诺药业(石家庄)有限公司 |
利奈唑胺中间体的制备及纯化方法
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012158399A1
(en)
|
2011-05-13 |
2012-11-22 |
Abbott Laboratories |
Condensed 2 - carbamoylpyridazinones as potassium channel modulators
|
CN102304125B
(zh)
*
|
2011-07-05 |
2014-02-19 |
浙江亚太药业股份有限公司 |
一种用于制备利奈唑胺的中间体
|
WO2013020930A1
(en)
|
2011-08-05 |
2013-02-14 |
Abbott Gmbh & Co. Kg |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
EP2753619A2
(de)
|
2011-09-08 |
2014-07-16 |
Cadila Healthcare Limited |
Verfahren und zwischenprodukte zur herstellung von rivaroxaban
|
TWI561521B
(en)
|
2011-10-14 |
2016-12-11 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
TWI571466B
(zh)
|
2011-10-14 |
2017-02-21 |
艾伯維有限公司 |
用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑
|
WO2013062966A2
(en)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Novel trpv3 modulators
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
CN103103229B
(zh)
*
|
2011-11-15 |
2015-03-18 |
安琪酵母股份有限公司 |
一种利奈唑酮中间体的合成方法
|
US8846741B2
(en)
|
2011-11-18 |
2014-09-30 |
Abbvie Inc. |
N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2013096223A1
(en)
|
2011-12-19 |
2013-06-27 |
Abbvie Inc. |
Trpv1 antagonists
|
US8969325B2
(en)
|
2011-12-19 |
2015-03-03 |
Abbvie Inc. |
TRPV1 antagonists
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2013149376A1
(en)
|
2012-04-02 |
2013-10-10 |
Abbott Laboratories |
Chemokine receptor antagonists
|
CA2870931A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Isoindolone derivatives
|
EP2850081A1
(de)
|
2012-05-11 |
2015-03-25 |
AbbVie Inc. |
Thiazolcarboxamidderivate zur verwendung als nampt-hemmer
|
US9193723B2
(en)
|
2012-05-11 |
2015-11-24 |
Abbvie Inc. |
NAMPT inhibitors
|
CA2873075A1
(en)
|
2012-05-11 |
2013-07-14 |
Abbvie Inc. |
Nampt inhibitors
|
MX2014013751A
(es)
|
2012-05-11 |
2015-08-07 |
Abbvie Inc |
Piridazina y derivados de piridina como inhibidores de nampt.
|
US20130317055A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
US20130317054A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
CN103420933B
(zh)
*
|
2012-05-26 |
2016-03-02 |
鲁南制药集团股份有限公司 |
一种利奈唑胺的制备方法
|
SG11201408324QA
(en)
|
2012-06-12 |
2015-01-29 |
Abbvie Inc |
Pyridinone and pyridazinone derivatives
|
US8796328B2
(en)
|
2012-06-20 |
2014-08-05 |
Abbvie Inc. |
TRPV1 antagonists
|
CN103570639B
(zh)
*
|
2012-08-08 |
2016-02-03 |
成都国弘医药有限公司 |
一种利奈唑胺的合成方法
|
US20140080813A1
(en)
|
2012-09-14 |
2014-03-20 |
AbbVie Deutschland GmbH & Co. KG |
Tricyclic quinoline and quinoxaline derivatives
|
JP6290217B2
(ja)
|
2012-09-14 |
2018-03-07 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
三環式キノリンおよびキノキサリン誘導体
|
CN102887871B
(zh)
*
|
2012-09-26 |
2015-12-02 |
苏州敬业医药化工有限公司 |
3-取代苯基-5-氨甲基噁唑烷-2-酮的制备方法
|
WO2014071990A1
(en)
|
2012-11-09 |
2014-05-15 |
Synthon Bv |
Process for making linezolid
|
MX2015012386A
(es)
|
2013-03-13 |
2016-02-03 |
Abbvie Inc |
Inhibidores de la cinasa cdk9.
|
JP2016516710A
(ja)
|
2013-03-13 |
2016-06-09 |
アッヴィ・インコーポレイテッド |
ピリジン系cdk9キナーゼ阻害薬
|
US9593104B2
(en)
|
2013-03-14 |
2017-03-14 |
Benova Labs Pvt. Limited |
Process for the preparation of oxazolidinone derivatives
|
BR112015023016A2
(pt)
|
2013-03-14 |
2017-07-18 |
Abbvie Deutschland |
derivados de oxindolo carregando um substituinte oxetano e uso do mesmo para tratamento de doenças relacionadas a vasopressina
|
JP2016510788A
(ja)
|
2013-03-14 |
2016-04-11 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
ホスホジエステラーゼ10a型の新規な阻害剤化合物
|
US9346813B2
(en)
|
2013-03-14 |
2016-05-24 |
Abbvie Inc. |
Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors
|
US9796708B2
(en)
|
2013-03-14 |
2017-10-24 |
Abbvie Inc. |
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
|
US20140275082A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
TW201444836A
(zh)
|
2013-03-14 |
2014-12-01 |
Abbvie Inc |
吡咯并[2,3-b]吡啶cdk9激酶抑制劑
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9586913B2
(en)
|
2013-04-25 |
2017-03-07 |
Symed Labs Limited |
Processes for the preparation of linezolid using novel intermediates
|
CA2924699A1
(en)
|
2013-10-17 |
2015-04-23 |
AbbVie Deutschland GmbH & Co. KG |
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
EP3057960B1
(de)
|
2013-10-17 |
2019-02-27 |
AbbVie Deutschland GmbH & Co. KG |
Aminochroman-, aminothiochroman- und amino-1,2,3,4-tetrahydrochinolin-derivate, pharmazeutische zusammensetzungen damit und verwendung in der therapie
|
US9840495B2
(en)
|
2013-12-20 |
2017-12-12 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
|
US9328112B2
(en)
|
2014-02-06 |
2016-05-03 |
Abbvie Inc. |
Tetracyclic CDK9 kinase inhibitors
|
EP3143023B1
(de)
|
2014-05-15 |
2018-04-11 |
AbbVie Deutschland GmbH & Co. KG |
Oxindolverbindungen mit einem co-gebundenen spirosubstituenten und verwendung davon zur behandlung von vasopressinvermittelten erkrankungen
|
CN105315231A
(zh)
*
|
2014-06-11 |
2016-02-10 |
成都自豪药业有限公司 |
利奈唑胺相关物质的制备方法
|
US9617226B2
(en)
|
2014-09-05 |
2017-04-11 |
AbbVie Deutschland GmbH & Co. KG |
Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
|
US9550754B2
(en)
|
2014-09-11 |
2017-01-24 |
AbbVie Deutschland GmbH & Co. KG |
4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US20180243298A1
(en)
|
2015-04-02 |
2018-08-30 |
Abbvie Inc. |
Trpv3 modulators
|
WO2017089458A1
(en)
|
2015-11-25 |
2017-06-01 |
AbbVie Deutschland GmbH & Co. KG |
Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disorders
|
CN105566242B
(zh)
*
|
2016-01-12 |
2017-12-05 |
江苏豪森药业集团有限公司 |
利奈唑胺及其中间体的制备方法
|
US9643939B1
(en)
|
2016-04-18 |
2017-05-09 |
Optimus Drugs Private Limited |
Process for the preparation of linezolid
|
USRE47606E1
(en)
|
2016-04-21 |
2019-09-17 |
Optimus Drugs Private Limited |
Process for the preparation of linezolid
|
AU2016403208B2
(en)
*
|
2016-04-21 |
2018-10-25 |
Optimus Drugs Pvt Ltd |
An improved process for the preparation of Linezolid
|
EP3452484B1
(de)
|
2016-05-07 |
2023-07-05 |
Fochon Pharmaceuticals, Ltd. |
Bestimmte proteinkinasehemmer
|
EP3544965A4
(de)
|
2016-11-28 |
2020-05-20 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Sulfoximin-, sulfonimidamid-, sulfondiimin- und diimidosulfonamidverbindungen als inhibitoren von indolamin-2,3-dioxygenase
|
EP3601255A1
(de)
|
2017-03-21 |
2020-02-05 |
AbbVie Deutschland GmbH & Co. KG |
Prolinamidverbindungen und deren azetidinanaloga, diespezifisch substituiertes benzylradikal tragen
|
ES2927182T3
(es)
|
2017-04-18 |
2022-11-03 |
Shanghai Fochon Pharmaceutical Co Ltd |
Agentes inductores de la apoptosis
|
KR20200141035A
(ko)
|
2018-03-14 |
2020-12-17 |
포천 파마슈티컬즈, 엘티디. |
TRK 키나제 억제제로서의 치환된 (2-아자비사이클로 [3.1.0] 헥산-2-일) 피라졸로 [1, 5-a] 피리미딘 및 이미다조 [1, 2-b] 피리다진 화합물
|
CN112771025B
(zh)
|
2018-03-23 |
2024-02-27 |
重庆复创医药研究有限公司 |
作为rock抑制剂的氘代化合物
|
CN109232457A
(zh)
*
|
2018-03-26 |
2019-01-18 |
华夏生生药业(北京)有限公司 |
一种利奈唑胺的制备方法
|
CN108892663A
(zh)
*
|
2018-08-10 |
2018-11-27 |
泰州申合泰尔生物医药有限公司 |
一种合成利伐沙班的中间体、合成方法和用途
|
CN113045509B
(zh)
*
|
2021-06-01 |
2021-10-22 |
上海翰森生物医药科技有限公司 |
利奈唑胺的工业生产方法
|